How to take Calocurb: three schedules, one 500 mg dose
How to take Calocurb: the brand's schedule, the CLINICAL label and the C4 trial protocol side by side, converted to mg of Amarasate a day.
Weight-loss supplements, weighed honestly.
What is Amarasate? Calocurb's hop extract, claim by claim
What is Amarasate? The New Zealand bitter hop extract inside Calocurb, with each brand claim set against the four human trials we read.
Calocurb vs Ozempic: one supplement trial vs a drug label
Calocurb is a supplement with one 24-week, 150-person trial (4.3% vs 0.5%). Ozempic is an FDA-approved diabetes drug with a boxed warning. Side by side.
Calocurb side effects: what the 24-week trial counted
Calocurb side effects, counted: the 24-week C4 trial's withdrawals and dose cuts for diarrhea and nausea, set against the brand pages' 'rare' and 'mild'.
Is Calocurb clinically proven? The C4 trial in numbers
Yes: one 24-week placebo-controlled trial, company-funded. Calocurb lost 4.3% vs 0.5% on placebo, a 3.8-point gap, at the label's maximum dose.
Lipofit Extreme Fat Burner 2.0: a fat burner recalled for an antidepressant and an industrial poison
FDA published a company announcement of a nationwide voluntary recall of Lipofit Extreme Fat Burner 2.0 over undeclared fluoxetine and 2,4-dinitrophenol. Two undeclared substances, two very different kinds of failure.
FORMI Weight Loss Complex, reviewed against the SlimBiome trial
Holland and Barrett's new own-label sachet is built on a fibre complex with a real open-access human trial behind it. That trial ran 150 minutes and never weighed anybody.
Two 'Esbelta' products, one named seller, and five substances the labels did not name
The FDA notified consumers about Esbelta Intense Loss and Esbelta Chupapanza Flat Belly on 18 August. This is not substitution and it is not underdosing — it is undeclared pharmaceutical ingredients, which no amount of label arithmetic would have caught.